Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

Bromodomain 2-selective BET inhibitors show antitumor effect in pediatric cancer models

Oct. 19, 2020

Mucolytic agent MUC-031 has beneficial effects in cystic fibrosis model

Oct. 16, 2020

KKC-080106 shows promising neuroprotective activity in preclinical models

Oct. 15, 2020

Astellas describes discovery of novel PET probe for fatty acid oxidation

Oct. 15, 2020

Direct AMPK activator opposes mitochondrial dysfunction, oxidative stress and inflammation in DPN

Oct. 14, 2020

Selective PDEB inhibitor shows promising preclinical results for the treatment of cocaine addiction

Oct. 9, 2020

ZLY-16 shows hepatoprotective effects in mouse model of NASH

Oct. 5, 2020

Discovery of novel selective HDAC6-selective inhibitor, PTG-0861

Sep. 22, 2020

PZ-1818, a dual-acting 5-HT6 receptor inverse agonist/MAO-B inhibitor

Sep. 17, 2020

SAB-402, a novel potent dual EGFR/HER4 tyrosine kinase inhibitor with promising activity in vivo

Sep. 16, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 28, 2025
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...
Evo 2 AI allows genome and epigenome modeling of all life domains
BioWorld MedTech
A new version of Evo, the AI developed at the Arc Institute that can be used to design genomes as long as that of a bacterium, has been retrained with the DNA...